预防性应用双歧杆菌能降低早产儿胆汁淤积症发生率，减轻其严重程度，减少胆

Prophylactic Bifidobacterium can reduce preterm children the incidence of cholestasis, lessening the severity, reduce the incidence of cholestatic liver damage, NEC and other complications, can reduce the incidence of FI, EUGR, etc., to promote the growth and development of preterm children , did not increase the incidence of sepsis, there are certain safety and reliability, but its long-term safety needs further study to verify.

Preventive application of Bifidobacteria can reduce the incidence of bile siltation in premature infants, reduce its severity, reduce the incidence of bile silt liver damage, NEC and other complications, can reduce the incidence of FI, EUGR and so on, promote the growth and development of premature babies, did not increase the incidence of sepsis, there is a certain safety and reliability, However, its long-term security still needs further research and verification.

The prophylactic application of Bifidobacterium can reduce the incidence of cholestasis of prematurity, reduce its severity, reduce the incidence of complications such as cholestasis liver damage and NEC, reduce the incidence of fi, eugr, etc., promote the growth and development of prematurity, without increasing the incidence of sepsis. There is a certain safety and reliability, but its long-term safety still needs further research and verification.